Alignment Healthcare (NASDAQ:ALHC) Insider Sells $198,167.04 in Stock

Key Points

• Alignment Healthcare insider Andreas Wagner sold 12,032 shares for a total of $198,167.04, resulting in a 5.90% decrease in his position.
• The company's stock is currently trading at $15.58 after a decline of 1.6%, with a 52-week range between $8.65 and $21.06.
• Analysts maintain a moderate outlook with an average price target of $18.83, and upgrades include a "strong-buy" rating from Stephens and "overweight" from KeyCorp.

Alignment Healthcare, Inc. (NASDAQ:ALHC - Get Free Report) insider Andreas Wagner sold 12,032 shares of the company's stock in a transaction that occurred on Monday, August 25th. The stock was sold at an average price of $16.47, for a total transaction of $198,167.04. Following the completion of the sale, the insider directly owned 192,043 shares of the company's stock, valued at $3,162,948.21. The trade was a 5.90% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Alignment Healthcare Trading Down 1.6%

Shares of ALHC traded down $0.26 during mid-day trading on Monday, hitting $15.58. The company's stock had a trading volume of 3,051,961 shares, compared to its average volume of 3,989,637. Alignment Healthcare, Inc. has a 52-week low of $8.65 and a 52-week high of $21.06. The company's 50-day moving average is $13.77 and its 200-day moving average is $15.30. The company has a debt-to-equity ratio of 2.29, a current ratio of 1.66 and a quick ratio of 1.66.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last posted its quarterly earnings results on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.07) by $0.14. The business had revenue of $1.02 billion during the quarter, compared to analysts' expectations of $960.25 million. Alignment Healthcare had a negative net margin of 1.53% and a negative return on equity of 43.68%. The business's quarterly revenue was up 49.0% on a year-over-year basis. During the same quarter last year, the company posted ($0.13) earnings per share. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, analysts expect that Alignment Healthcare, Inc. will post -0.69 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on ALHC shares. UBS Group increased their price objective on shares of Alignment Healthcare from $16.00 to $17.00 and gave the stock a "neutral" rating in a research note on Friday, May 2nd. Zacks Research upgraded shares of Alignment Healthcare to a "hold" rating in a research note on Friday, August 8th. KeyCorp upgraded shares of Alignment Healthcare from a "sector weight" rating to an "overweight" rating and set a $21.00 price objective on the stock in a research note on Monday. Barclays upgraded shares of Alignment Healthcare from an "underweight" rating to an "equal weight" rating and increased their price objective for the stock from $9.00 to $13.00 in a research note on Thursday, July 31st. Finally, Stephens upgraded shares of Alignment Healthcare to a "strong-buy" rating in a research report on Monday, June 2nd. One research analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating and four have issued a Hold rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and an average price target of $18.83.

Hedge Funds Weigh In On Alignment Healthcare

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. State of Wyoming raised its position in Alignment Healthcare by 133.9% in the 2nd quarter. State of Wyoming now owns 20,406 shares of the company's stock valued at $286,000 after purchasing an additional 11,683 shares in the last quarter. Caxton Associates LLP acquired a new stake in Alignment Healthcare in the 2nd quarter valued at about $240,000. Tower Research Capital LLC TRC raised its position in Alignment Healthcare by 2,098.8% in the 2nd quarter. Tower Research Capital LLC TRC now owns 19,679 shares of the company's stock valued at $276,000 after purchasing an additional 18,784 shares in the last quarter. Tidal Investments LLC raised its position in Alignment Healthcare by 4.9% in the 2nd quarter. Tidal Investments LLC now owns 18,094 shares of the company's stock valued at $253,000 after purchasing an additional 852 shares in the last quarter. Finally, Gilder Gagnon Howe & Co. LLC acquired a new stake in Alignment Healthcare in the 2nd quarter valued at about $2,039,000. Hedge funds and other institutional investors own 86.19% of the company's stock.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.